))
Emergency COVID-19 TRIPS Waiver: With U.S. Now Supporting, What’s Next?
Manage episode 365981901 series 3484042
Innhold levert av Rethink Trade. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Rethink Trade eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
On May 5th, the Biden administration announced its support for an emergency COVID-19 waiver of “TRIPS” intellectual property barriers at the World Trade Organization. As we’ve detailed in previous episodes, 100 mainly developing countries have pushed for a TRIPS waiver to facilitate more production of COVID-19 vaccines, tests and treatments around the world.
By reversing the Trump administration block against waiver negotiations, the Biden-Harris administration created momentum for a waiver to be adopted. And made clear saving lives is the priority.
But while we celebrate this historic U.S. announcement and the efforts of people around the world to get a waiver, the Pharma lobby is gearing up to derail, weaken or delay any waiver. In this episode, we reflect on the U.S. campaign for a TRIPS waiver, and the fight still to come as we work to secure the fastest possible agreement on a waiver covering all intellectual property barriers for COVID-19 vaccines, tests & treatments.
Learn more at rethinktrade.org.
Music: Groove Grove by Kevin MacLeod. Link: https://incompetech.filmmusic.io/song/3831-groove-grove. License: http://creativecommons.org/licenses/by/4.0/
72 episoder
Del
